Sodium Nitroprusside
NDC 14335-132, Sodium Nitroprusside, injection, solution, from Hainan Poly Pharm. Co., Ltd..
- Product NDC
- 14335-132
- Status
- Listed
- Labeler
- Hainan Poly Pharm. Co., Ltd.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215846
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/14335-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM NITROPRUSSIDE.2 mg/mL
Pharmacologic classes
Vasodilation [PE]; Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 14335-132-01 | 14335013201 | 1 VIAL in 1 CARTON (14335-132-01) / 50 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/72a9b7df-3a2f-4c16-93a9-b645bc0e8143
Use it
Look up 14335-132 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/14335-132 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 14335-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.